ePrints

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial

Lookup NU author(s): Professor Phil White, Dr Rachel Lakey

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gbitz G, Pillips SJ, Arauz A, Baigent C, Chadwick D, Tyrrell P, Lowe G, Collins R, Bath P, VanGijn J, Gray R, Hart R, Yusuf S, Clark A, Perry D, Soosay V, Buchanan D, Grant S, Sakka E, Drever J, Walker P, Herath I, Brown AL, Chmielnik P, Armit C, Walton A, Hautvast M, Lewis S, Heron G, Odusanya S, Linksted P, Kane I, Whiteley W, Sellar R, White P, Keston P, Farrell A, Morris Z, Miranda H, Blackwell L, IST-3 collaborative group

Publication type: Article

Publication status: Published

Journal: Lancet

Year: 2012

Volume: 379

Issue: 9834

Pages: 1232-1236

Print publication date: 23/06/2012

ISSN (print): 0140-6736

ISSN (electronic): 1474-547X

Publisher: The Lancet Publishing Group

URL: http://dx.doi.org/10.1016/S0140-6736(12)60768-5

DOI: 10.1016/S0140-6736(12)60768-5

Altmetrics

Share